Sallam Malik, Al-Mahzoum Kholoud, Yousef Zainab Mansour, Alfouzan Jeelan Saleh, Alharbi Maryam Jamal, Alsubaiei Mohammad Khaled, Albalwah Mohammed Yahya M, Shehadeh Mohammad W, Obeidat Rawan J, Yaseen Khaled O, Abdelaziz Doaa H, Salim Nesreen A, Sallam Mohammed, Barakat Muna
Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan.
Ther Adv Vaccines Immunother. 2025 Feb 27;13:25151355251324384. doi: 10.1177/25151355251324384. eCollection 2025.
Respiratory syncytial virus (RSV) poses a significant respiratory health risk to senior citizens, contributing substantially to hospitalizations and mortality. With the recent approval of three RSV vaccines for the elderly, it is critical to understand the factors that can shape the RSV vaccination attitudes to inform public health strategies that can enhance uptake among this vulnerable population.
This study aimed to investigate the potential factors that could influence the attitudes toward RSV vaccination among senior citizens in Arab countries.
A multinational cross-sectional study, adhering to STROBE guidelines, was conducted using a survey instrument previously validated through exploratory factor analysis to assess attitudes toward the newly approved RSV vaccine.
A self-administered online survey was distributed conveniently among senior citizens mainly across five Arab countries. The survey collected data on demographics, vaccination history, and key constructs related to RSV vaccine attitude, including "Fear," "Information," "Accessibility," "Benefits," and "Conspiracy."
A total of 483 participants were included in the study, with the majority from five Arab countries: Jordan ( = 239, 49.5%), Kuwait ( = 74, 15.3%), Egypt ( = 68, 14.1%), Saudi Arabia ( = 51, 10.6%), and the UAE ( = 23, 4.8%), alongside participants from other Arab nations ( = 28, 5.8%). Among the respondents, 51.1% ( = 247) expressed acceptance of the RSV vaccine, 22.4% ( = 108) were hesitant, and 26.5% ( = 128) exhibited refusal. Multivariate analysis identified perceived benefits (β = 0.484, < 0.001), information needs (β = 0.229, < 0.001), and previous vaccination history (β = 0.087, = 0.016) as significant positive predictors of vaccine acceptance. Conversely, stronger conspiracy beliefs (β = -0.083, = 0.035) were associated with vaccine resistance. Fear and accessibility were not significant predictors of vaccine attitudes.
The findings showed that perceived benefits, access to reliable information, previous vaccination history, and conspiracy beliefs are essential to promote RSV vaccine acceptance among Arab seniors. These factors are recommended to improve RSV vaccine uptake in this vulnerable population.
呼吸道合胞病毒(RSV)对老年人的呼吸健康构成重大风险,在住院率和死亡率方面占很大比例。随着近期三种针对老年人的RSV疫苗获批,了解影响RSV疫苗接种态度的因素对于制定公共卫生策略以提高这一弱势群体的疫苗接种率至关重要。
本研究旨在调查可能影响阿拉伯国家老年人对RSV疫苗接种态度的潜在因素。
一项遵循STROBE指南的跨国横断面研究,使用先前通过探索性因素分析验证的调查工具来评估对新获批的RSV疫苗的态度。
一项自填式在线调查在主要来自五个阿拉伯国家的老年人中方便地进行了分发。该调查收集了有关人口统计学、疫苗接种史以及与RSV疫苗态度相关的关键构念的数据,包括“恐惧”“信息”“可及性”“益处”和“阴谋论”。
共有483名参与者纳入研究,大多数来自五个阿拉伯国家:约旦(n = 239,49.5%)、科威特(n = 74,15.3%)、埃及(n = 68,14.1%)、沙特阿拉伯(n = 51,10.6%)和阿联酋(n = 23,4.8%),还有来自其他阿拉伯国家的参与者(n = 28,5.8%)。在受访者中,51.1%(n = 247)表示接受RSV疫苗,22.4%(n = 108)持犹豫态度,26.5%(n = 128)表示拒绝。多变量分析确定感知到的益处(β = 0.4,84,P < 0.001)、信息需求(β = 0.229,P < 0.001)和既往疫苗接种史(β = 0.087,P = 0.016)是疫苗接受度的显著正向预测因素。相反,更强的阴谋论信念(β = -0.083,P = 0.035)与疫苗抗拒相关。恐惧和可及性不是疫苗态度的显著预测因素。
研究结果表明,感知到的益处、获得可靠信息、既往疫苗接种史和阴谋论信念对于促进阿拉伯老年人接受RSV疫苗至关重要。建议利用这些因素来提高这一弱势群体的RSV疫苗接种率。